PRODUCT DETAIL

Injexate 50 mg/ml injekčný roztok v naplnenej injekčnej striekačke

Code

6699B

MA number

29/0462/15-S

Product Form:

sol iru 1x0,25 ml/12,5 mg (striek.inj.skl.napl. s ihlou)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

MAH, country:

Accord Healthcare Polska Sp. z o.o., Poland

Therapeutic Class:

29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04	Immunosuppressants
L04A	Immunosuppressants
L04AX	Other immunosuppressants
L04AX03	Methotrexate

Shelf life:

Container:

pre-filled syringe

Route of admin.:

Subcutaneous use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(3) hybrid application
MA issued:	26.11.2015
Pediatric indication:	Yes
Pediatric posology:	Yes
Pediatric warnings:	Yes
SPC:	SPC_Injexate 50 mg-ml injekčný roztok naplnený v injekčnej striekačke_07.2024.pdf
PIL:	PIL_Injexate 50 mg_ml injekčný roztok naplnený v injekčnej striekačke_12.2024.pdf
Safety feature	Yes
Data update:	23.04.2025